Skip to content

Clinical trials

Terminated Idiopathic Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Status: Terminated Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20082
20094
20101
20111
20122
20133
20141
20151
20162
20175
20187
20195
20203
20212
20222
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
GlaxoSmithKline3
InterMune3
Novartis Pharmaceuticals3
Boehringer Ingelheim2
Celgene2
Hoffmann-La Roche2
Kyntra Bio2
Lakefront Biotherapeutics NV2
Alicia Gerke1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis49
Pulmonary Fibrosis16
Fibrosis8
Lung Diseases, Interstitial7
Lung Diseases4
Idiopathic Interstitial Pneumonias3
Gastroesophageal Reflux2
Hypertension, Pulmonary2
Pulmonary Disease, Chronic Obstructive2
Respiration Disorders2

Trials

Showing 51 to 49 of 49. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.